transmiss
gastroenter
tge
porcin
epidem
diarrhea
ped
sever
enter
diseas
newborn
piglet
character
extrem
high
mortal
well
devast
econom
consequ
swine
industri
etiolog
agent
respons
diseas
coronavirus
tgev
pedv
respect
tgev
isol
first
time
japan
england
report
diseas
viru
replic
cytoplasm
matur
absorpt
epitheli
cell
present
tip
villi
small
intestin
function
coronaviru
spike
protein
attach
cell
surfac
fusion
viral
membran
cellular
membran
protein
major
induc
tgevneutr
antibodi
therefor
excel
target
protein
candid
vaccin
develop
relev
epitop
neutral
map
ntermin
domain
protein
four
antigen
site
identifi
within
first
residu
protein
first
polypeptid
chain
protein
appear
immunogen
rest
sequenc
region
would
locat
globular
part
peplom
expos
fibrillar
ctermin
portion
protein
previou
report
show
immunogen
dna
vaccin
compris
main
antigen
site
superior
vaccin
contain
total
length
gene
pedv
relat
tgev
bear
similar
structur
well
clinic
diseas
lesion
induc
pedv
first
separ
belgium
unit
kingdom
diseas
character
sever
diarrhea
vomit
dehydr
death
mortal
rate
sinc
diseas
frequent
broken
mani
swinerais
countri
result
sever
econom
loss
asia
notabl
china
japan
korea
ped
outbreak
report
respons
death
piglet
japan
ped
caus
death
neonat
piglet
also
weight
loss
fatten
pig
due
pedvinduc
diarrhea
therefor
import
develop
effect
vaccin
prevent
pedv
infect
pedv
protein
also
play
import
role
induct
neutral
antibodi
specif
receptor
bind
cell
membran
fusion
protein
cleav
subunit
furinlik
proteas
due
lack
appropri
cleavag
site
domain
residu
domain
artifici
defin
protein
residu
previou
report
shown
main
neutral
epitop
locat
domain
thought
form
globular
part
protein
sun
et
al
report
epitop
region
design
aa
domain
pedv
protein
highli
conserv
across
pedv
isol
region
capac
induc
product
viru
neutral
antibodi
moreov
immun
serum
show
bind
abil
nativ
protein
pedv
aa
aa
two
linear
epitop
domain
furthermor
ysnigvck
lqdgqvki
two
core
epitop
domain
respect
locat
protein
pedv
accord
sequenc
inform
neutral
epitop
transmiss
gastroenter
viru
tgev
neutral
epitop
domain
coe
aa
respons
induc
viru
neutral
antibodi
domain
pedv
protein
identifi
highli
conserv
pedv
strain
novel
antigen
domain
motif
excel
immunogen
identifi
ctermin
portion
protein
elicit
strong
antibodi
respons
induc
neutral
antibodi
protect
neonat
older
anim
diseas
vaccin
effect
prevent
measur
although
mani
commerci
vaccin
tradit
inactiv
vaccin
mani
defici
therefor
two
diseas
still
major
problem
swine
industri
protein
consid
primari
target
antigen
develop
effect
vaccin
coronavirus
report
compar
effici
vaccin
pedv
therefor
evalu
combin
vaccin
approach
base
plasmiddriven
express
two
protein
tgev
protein
pedv
protein
use
mous
model
investig
first
step
develop
bival
vaccin
tge
ped
plasmid
contain
fulllength
gene
tgev
strain
purdu
construct
laboratori
common
clone
techniqu
use
templat
pcr
amplif
sens
primer
gggggctagcccatgaaaaaactatttg
antisens
primer
ccccgaattcttagtttgtctaataa
contain
nhei
ecori
restrict
enzym
site
underlin
use
pcr
plasmid
easyt
contain
fulllength
gene
pedv
strain
construct
laboratori
common
clone
techniqu
use
templat
pcr
amplif
sens
primer
gggggtcgacatggatgtcactaggtgcc
two
antisens
primer
ccccgcggccgctcatctctgcacgtggac
contain
sali
noti
restrict
enzym
site
underlin
use
pcr
amplif
profil
tgev
gene
primer
follow
min
follow
cycl
min
min
min
final
extens
min
perform
end
cycl
period
amplif
profil
gene
primer
pedv
gene
primer
gene
except
anneal
temperatur
rais
respect
pcr
product
purifi
prior
clone
eukaryot
express
vector
pire
takara
japan
briefli
digest
nhei
ecori
insert
multipl
clone
site
mc
pire
vector
result
recombin
plasmid
pedv
digest
sali
noti
insert
mc
b
respect
result
recombin
plasmid
design
pire
pire
respect
clone
step
shown
figur
transform
clone
pick
valid
dna
sequenc
tgev
pedv
protein
express
ecoli
respect
lymphocyt
stimul
assay
brief
two
recombin
plasmid
compris
half
tgev
gene
compris
pedv
gene
bp
construct
transform
ecoli
plyss
novagen
germani
express
purif
tgev
protein
detail
recent
refer
pedv
protein
also
obtain
accord
similar
protocol
express
fuse
protein
name
respect
plasmid
dna
pire
pire
pire
chromatograph
purifi
bacteri
lysat
qiagen
germani
precipit
wash
ethanol
plasmid
dissolv
pb
final
concentr
immunofluoresc
assay
cell
american
type
cultur
collect
atcc
cultur
confluenc
plate
approx
h
transform
pire
pire
pire
use
lipofectamin
next
day
indirect
immunofluoresc
assay
perform
modif
describ
fixat
formalin
cell
incub
min
triton
follow
incub
h
polyclon
antisera
dilut
bsa
pedv
prepar
laboratori
tgev
prepar
laboratori
wash
pb
cell
incub
dark
fitclabel
goat
antirabbit
igg
h
green
fluoresc
signal
analyz
fluoresc
microscopi
leica
germani
western
blot
plasmid
transform
cell
plate
cell
transfect
empti
vector
use
control
hour
cell
treat
triton
centrifug
rpm
minut
respect
supernat
subject
sdspage
protein
electron
transfer
nitrocellulos
nc
membran
nc
membran
block
overnight
use
nonfat
dri
milk
pbst
follow
incub
antitgev
antipedv
serum
dilut
pbst
h
membran
incub
horseradish
peroxidas
hrp
conjug
goat
antirabbit
igg
dilut
pbst
h
complet
wash
pbst
protein
band
visual
use
chemiluminesc
reagent
roch
switzerland
anim
studi
preapprov
anim
ethic
committe
northeast
agricultur
univers
china
approv
id
prior
dna
vaccin
sixweekold
kunm
mice
harbin
veterinari
research
institut
separ
group
tabl
inject
medial
vastu
muscl
lidocain
hydrochlorid
ga
needl
vv
pb
min
mice
receiv
similar
inject
pire
pire
pire
pedv
pire
pire
attenu
vaccin
tgev
pedv
pire
pb
mice
boost
twice
interv
shown
tabl
peripher
blood
collect
orbit
bleed
h
day
postimmun
dpi
serum
lymphocyt
subsequ
prepar
detect
tgev
pedv
specif
antibodi
recombin
protein
purifi
pgex
pet
transform
bacteri
cell
dilut
elisa
perform
accord
publish
protocol
modif
assess
antibodi
bind
elisa
well
incub
ophenylenediamin
dihydrochlorid
substrat
min
reaction
termin
well
read
nm
peripher
blood
lymphocyt
purifi
use
lymphocyt
separ
solut
invitrogen
usa
accord
manufactur
instruct
cell
suspend
cellsml
rpmi
medium
contain
serum
prepar
describ
prepar
cell
incub
fitcconjug
cell
antibodi
peconjug
cell
antibodi
dilut
zhongshan
china
min
incub
cell
wash
cold
pb
suspend
pb
subject
flow
cytometri
splenic
lymphocyt
similarli
prepar
analyz
splenocyt
immun
mice
prepar
lymphocyt
prolifer
assay
describ
prepar
cell
cellsml
suspend
contain
serum
transfer
flatbottom
plate
well
medium
contain
either
purifi
recombin
protein
concanavalin
sigma
ad
treatment
perform
triplic
plate
incub
h
supplement
mtt
incub
addit
h
reaction
termin
ad
equal
volum
dmso
incub
plate
room
temperatur
min
prolifer
measur
valu
prolifer
lymphocyt
pbmc
vaccin
control
mice
similarli
monitor
determin
mice
gener
tgev
pedv
neutral
antibodi
sera
dilut
dnavaccin
mice
mix
equal
volum
pedv
tgev
pfuml
h
incub
treat
virus
use
infect
cultur
swine
testi
st
cell
african
green
monkey
kidney
vero
cell
plate
respect
follow
overlay
methylcellulos
plate
incub
atmospher
examin
daili
day
tgev
pedv
specif
cytopath
effect
cpe
serum
level
analyz
detect
kit
excel
bio
china
accord
manufactur
instruct
standard
curv
gener
use
control
dilut
pb
differ
concentr
begin
pgml
follow
twofold
serial
dilut
pgml
pgml
dilut
subsequ
coat
onto
elisa
plate
overnight
sera
dpi
mice
also
coat
onto
elisa
plate
use
primari
antibodi
parallel
experi
evalu
virusderiv
respons
hrpconjug
goatanti
mous
use
secondari
antibodi
control
experi
analysi
mous
sera
valu
therefor
pgml
immun
mice
determin
rel
standard
curv
serum
level
similarli
analyz
use
detect
kit
excel
bio
china
control
seriallydilut
twofold
pb
pgml
pgml
coat
onto
elisa
plate
overnight
elisa
perform
valu
pgml
determin
rel
standard
curv
cytotox
analyz
use
lactat
dehydrogenas
ldh
releas
assay
kit
accord
manufactur
instruct
jiancheng
nanj
china
use
splenic
lymphocyt
blood
dpi
mice
lymphocyt
suspend
complet
rpmi
medium
use
effector
cell
simultan
target
st
vero
cell
infect
tgev
pedv
respect
titer
h
effector
cell
mix
sensit
target
cell
ad
well
roundbottom
micropl
incub
h
centrifug
rpm
min
supernat
collect
transfer
fresh
flatbottom
plate
follow
addit
ldh
assay
reagent
mixtur
allow
incub
min
measur
spontan
releas
ldh
determin
use
sampl
prepar
target
cell
cultur
medium
alon
maximum
ldh
releas
measur
use
sampl
prepar
lysi
target
cell
medium
contain
vv
triton
ctl
calcul
use
follow
equat
experiment
releasespontan
releas
maximum
releasespontan
releas
x
experi
perform
triplic
statist
analysi
data
perform
use
spss
softwar
p
p
defin
statist
signific
statist
signific
respect
sequenc
analysi
pire
pire
show
ident
sequenc
compar
genbank
access
number
respect
analysi
immunofluoresc
microscopi
show
transfect
cell
pire
pire
plasmid
result
express
protein
respect
tgev
pedv
figur
western
blot
confirm
vitro
express
gene
interest
figur
determin
immun
respons
mice
dna
vaccin
plasmid
appli
intramuscular
inject
differ
time
vaccin
anim
sacrif
analyz
variou
paramet
immun
reaction
prolifer
spleen
lymphocyt
upon
stimul
purifi
protein
either
tgev
pedv
analyz
mtt
assay
shown
figur
stimul
protein
dpi
prolifer
level
spleen
lymphocyt
mice
inject
pire
pire
increas
compar
control
cell
increas
highli
signific
p
dpi
prolifer
level
cell
mice
inject
pire
pire
somewhat
lower
still
significantli
increas
compar
control
cell
p
contrast
prolifer
level
lymphocyt
anim
immun
pire
pire
pedv
highest
dpi
p
signific
differ
p
observ
group
pire
pire
pedv
prolifer
valu
upon
stimul
protein
shown
figur
dpi
prolifer
level
spleen
lymphocyt
anim
inject
pire
pire
pire
significantli
increas
p
rel
pb
pire
control
furthermor
valu
pire
group
somewhat
higher
pire
group
p
dpi
chang
prolifer
level
rel
control
remain
highli
signific
p
irrespect
plasmid
use
vaccin
pire
pire
signific
differ
p
observ
dpi
dpi
valu
assay
use
pbmc
determin
prolifer
peripher
blood
lymphocyt
upon
stimul
protein
perform
dpi
prolifer
blood
lymphocyt
mice
immun
pire
pire
significantli
increas
p
rel
pb
pire
control
figur
differ
remain
signific
p
cell
analyz
dpi
valu
two
time
point
similar
case
mice
immun
pire
pire
group
prolifer
valu
dpi
slightli
significantli
lower
p
shown
figur
stimul
protein
prolifer
pbmc
increas
dpi
mice
immun
pire
pire
p
rel
pb
pire
control
group
pire
prolifer
significantli
increas
dpi
wherea
prolifer
pbmc
mice
immun
pire
similar
time
point
flow
cytometri
data
show
level
lymphocyt
peripher
blood
gradual
increas
dpi
dpi
figur
level
cell
figur
mice
immun
pire
significantli
p
increas
alreadi
dpi
dpi
number
cell
mice
immun
pire
also
increas
valu
mice
immun
pire
higher
case
cell
cell
number
increas
dpi
mice
immun
pire
pire
similar
extent
figur
increas
dpi
observ
pire
group
p
wherea
pire
group
dpi
slight
increas
determin
spleen
lymphocyt
number
examin
flow
cytometri
result
show
gradual
increas
dpi
dpi
figur
highest
valu
determin
pire
group
dpi
analys
spleenderiv
cell
figur
anim
immun
pire
pire
show
clear
increas
cell
number
dpi
serum
antibodi
level
pedv
tgev
examin
mice
immun
plasmid
dna
use
indirect
elisa
gener
dpi
level
pedv
antibodi
mice
immun
pire
pire
similar
significantli
p
higher
anim
inject
pb
empti
vector
figur
shown
figur
level
tgev
antibodi
began
increas
dpi
reach
peak
dpi
dpi
antibodi
level
decreas
significantli
p
pire
group
pire
group
assay
neutral
anibodi
pedv
figur
show
concentrationdepend
decreas
inhibitori
activ
sera
mice
immun
pire
pire
pedv
pire
pire
higher
titer
determin
sera
mice
immun
pire
pedv
pire
construct
compar
anim
inject
pire
pire
construct
neutral
antibodi
tgev
figur
also
detect
mice
immun
pire
pire
pire
pronounc
differ
detect
three
group
anim
chang
serum
level
immun
mice
analyz
use
elisa
result
show
level
mice
treat
pire
pire
pedv
pire
pire
pire
vaccin
significantli
higher
mice
treat
pb
pire
highest
level
found
induc
pire
p
tabl
howev
level
treatment
group
fluctuant
especi
pire
pire
group
induc
product
level
even
much
lower
p
pb
pire
control
pire
group
higher
p
pire
highli
signific
p
pb
pire
control
cytotox
analyz
use
ldh
releas
assay
result
show
ctl
function
peripher
blood
mice
treat
pire
higher
p
control
cell
significantli
lower
valu
determin
pire
pire
group
p
addit
ctl
function
pire
group
higher
p
pire
pedv
group
figur
similar
way
ctl
function
spleen
cell
determin
anim
immun
pire
pire
pedv
pire
pire
pire
vaccin
case
valu
significantli
increas
compar
control
cell
figur
preval
tge
ped
may
lead
sever
econom
loss
swinerais
countri
far
effect
prevent
measur
vaccin
dna
vaccin
induc
complet
immun
respons
provid
heterolog
cross
protect
easili
prepar
polyval
vaccin
document
tgevpedv
contain
main
neutral
epitop
one
report
indic
immunogen
dna
plasmid
bear
tgev
gene
superior
anoth
version
contain
fulllength
gene
contrast
report
regard
compar
analysi
effici
dna
plasmid
therefor
studi
aim
evalu
immun
respons
induc
dna
plasmid
encod
tgev
protein
pedv
protein
use
mous
model
pire
vector
intern
ribosom
entri
site
ire
deriv
encephalomyocard
viru
ecmv
two
multipl
clone
site
mc
b
allow
product
transcript
translat
independ
particip
ribosom
time
addit
pire
vector
cmv
promot
high
express
foreign
gene
enhancerpromot
allow
enhanc
gene
express
mani
host
therefor
gene
interest
studi
clone
pire
vector
immunufluoresc
assay
western
blot
indic
vitro
express
tgev
pedv
pedv
protein
success
clear
level
neutral
antibodi
import
indic
evalu
effect
vaccin
studi
igg
level
pedv
antibodi
pire
pire
group
increas
dpi
differ
group
signific
addit
valu
pire
pire
group
peak
dpi
decreas
thereaft
differ
two
group
also
signific
igg
antibodi
level
tgev
two
group
began
increas
dpi
reach
peak
dpi
dpi
antibodi
level
decreas
dramat
p
pire
group
wherea
signific
chang
observ
p
pire
group
result
show
recombin
plasmid
pire
contain
fulllength
protein
pdev
better
elicit
immun
respons
pedv
pire
encod
portion
protein
igg
antibodi
level
viru
neutral
assay
show
pire
pire
group
could
elicit
humor
immun
respons
pedv
tgev
protein
respect
plasmid
pire
effici
induc
neutral
antibodi
pire
cell
import
effector
cell
immun
respons
activ
caus
secret
cytokin
advanc
cellular
humor
immun
respons
mediat
ctl
activ
monitor
ctl
activ
provid
good
readout
immun
stimul
studi
spleen
bloodderiv
lymphocyt
immun
mice
clearli
show
immun
pire
pire
significantli
induc
cell
prolifer
stimul
purifi
recombin
protein
higher
lymphocyt
prolifer
pire
group
pire
group
exogen
protein
even
inactiv
pathogen
intern
process
via
endolysosom
pathway
result
degrad
protein
yield
peptid
associ
mhcii
molecul
may
stimul
antibodi
respons
also
product
helper
cell
necessari
specif
antibodi
ctl
product
activ
cell
classifi
least
two
subgroup
phenotyp
predominantli
associ
phenotyp
character
increas
level
associ
improv
humor
respons
mucos
immun
respons
studi
number
lymphocyt
peripher
blood
spleen
reach
peak
dpi
number
cell
mice
immun
pire
higher
p
pire
group
chang
serum
level
immun
mice
analyz
result
show
level
mice
treat
dna
vaccin
significantli
higher
addit
level
induc
pire
higher
group
p
howev
level
treatment
group
fluctuant
especi
pire
pire
group
level
even
much
lower
p
pb
pire
control
result
may
explain
high
level
promot
cell
differenti
time
restrain
cell
differenti
downregul
humor
immun
respons
tendenc
consist
igg
antibodi
chang
dpi
sever
report
also
suggest
level
antigen
present
affect
profil
follow
increas
understand
mechan
antigen
process
present
gener
mhci
restrict
cytolyt
tlymphocyt
ctl
respons
import
cellular
immun
becam
signific
reason
seek
specif
gener
ctl
includ
activ
directli
kill
infect
cell
versu
directli
kill
viru
bacteria
also
fact
ctl
focu
antigen
access
antibodi
elicit
ctl
respons
antigen
need
present
cytoplasm
antigenpres
cell
apc
newli
synthes
protein
process
proteosom
certain
result
peptid
bind
nascent
mhci
molecul
export
via
golgi
cell
surfac
therefor
specif
ctl
activ
could
reflect
activ
lymphocyt
studi
number
lymphocyt
peripher
blood
spleen
reach
peak
dpi
number
cell
mice
immun
pire
higher
p
pire
group
similar
lymphocyt
chang
activ
determin
ctl
assay
show
ctl
function
peripher
blood
mice
treat
pire
higher
p
pb
control
significantli
lower
pire
group
p
studi
ctl
function
spleen
cell
mirror
higher
effici
pire
group
compar
pire
group
summari
best
knowledg
first
time
immunolog
efficaci
trigger
pedv
protein
tgev
protein
compar
use
mous
model
recombin
plasmid
pire
pire
could
elicit
mice
cellular
immun
tcell
respons
well
humor
respons
gener
ctl
helper
cell
particularli
cell
well
specif
neutral
antibodi
pedv
tgev
respect
report
antigen
domain
gene
could
elicit
strong
antibodi
respons
induc
neutral
antibodi
excel
immunogen
ctermin
portion
protein
result
confirm
fulllength
pedv
gene
induc
better
immun
respons
ntermin
half
alon
mice
suscept
infect
tgev
pedv
use
anim
model
perform
challeng
experi
evalu
protect
rate
dna
construct
howev
observ
good
immun
respons
dna
plasmid
speci
basi
studi
studi
includ
usag
pig
optim
immun
procedur
well
evalu
host
immun
protect
induc
dna
plasmid
develop
effect
dna
vaccin
control
tge
ped
